SPOTLIGHT -
Early Warnings: Neuropsychiatric Manifestations of Huntington Disease
Neuropsychiatric manifestations of Huntington disease can present decades before the motor symptoms become apparent, making the role of the psychiatrist all the more important.
Psychiatry and the Shores of Social Construction: Sami Timimi, MD
Are current systems of mental health care alienating children and adults from the meaning inherent in their own emotional difficulties?
Whose Turn Should It Be? The Ethics of COVID-19 Vaccine Allocation
Leaders are struggling to justly distribute the coveted vaccine, as their are many vexing ethical issues surrounding COVID-19.
Does Cannabis Cause Psychosis?
A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.
Adult-Onset ADHD Raises Questions
Before starting to prescribe stimulants to every adult who cannot concentrate, it is important to take a closer look at the research.
Clinician, Patients Take the Fight for Psilocybin To Court
Should a patient at the end of her life have access to psilocybin, even if it’s illegal?
What to Expect When Your Patients With ADHD Are Expecting
A new study provides guidance for clinicians discussing the risks of ADHD medications with their pregnant patients.
One Year With COVID-19
The COVID-19 outbreak will eventually end, but public health experts expect this will not be the last pandemic. Will we have learned the right lessons so we can more successfully weather the next one?
Psilocybin Revisited: The Science Behind the Drug and Its Surprising Therapeutic Potential
Psilocybin may be useful for examining interactions between serotonin-dopamine systems and various psychiatric conditions, such as schizophrenia.
A New CME: Continuing Moral Education
Every phase of the COVID-19 pandemic brings new ethical challenges.
Handling the Highs and Lows of Ultradian Bipolar Disorder—and Love
A high-powered lawyer faces her toughest opponent yet: mental illness stigma.
Helen Flanders Dunbar: The Mother of Psychosomatic Medicine
The rise and fall of a brilliant medical pioneer.
The Existential Fallout of COVID-19
During the pandemic, Albert Camus’ existential novels have become newly popular—and with good reason.
How Will Patients React to Medications? The Answer May Be in Their Genes
A study finds that testing genetic variations can predict outcomes and medication blood levels in patients with depression.
Bard Self Disclosure
Catharsis expressed in a pen, it was a tool to get through the hard times, even medical school.
Psychiatric Residency Interview
My life pasted on his wall to analyze, a flash of insight came to me: Training had begun.
A People’s History of Depression: Jonathan Sadowsky, PhD
The story of depression, through time and around the world.
Journal Publication Brings Good News for Novel Schizophrenia Treatment
The chief medical officer of Karuna shares his thoughts exclusively with Psychiatric Times.
A Young Man Presents With Perplexing Symptoms: What Is Going on Here?
Psychiatrists face diagnostic puzzles almost every day. Find out how one clinician cracked a tough case.
Addressing Smoking: Is Varenicline the Answer?
Many patients with bipolar and other psychiatric disorders believe it is better to wait to address cigarette and other nicotine use. Here is why that is not necessarily the case.
Are You Connected?
Join the conversation on Psychiatric Times
An Affair to Remember
There are many reasons to look forward, armed with lessons learned and new research on the horizon.
ADHD Treatment Gets the Green Light
The FDA has approved the New Drug Application for a once-daily ADHD treatment.
Psychiatry 2021: Team Psychiatry
Providing quality mental health care in all treatment settings requires one crucial element: teamwork.
Can This Cancer Treatment Cause Manic Episodes?
A case report and literature review of intrathecal methotrexate-induced mania.
Sleepiness Treatment Under FDA Review
If approved, this formulation of sodium oxybate will be the first once-nightly oxybate treatment for daytime sleepiness.
Treatment Dilemmas in Depression and Coronary Heart Disease
How does relapse prevention for depression in patients with coronary heart disease differ from relapse prevention in those with depression alone? That question and more answered.
The Cardiovascular Consequences of Drug Use
Some commonly used drugs and narcotics have serious cardiovascular effects.
A Tribute to Black History Month
As February comes to a close, we reflect on this month's contributions.
Can COVID-19 Enter the Brain?
A new study considers how the virus might enter the brain and cause cognitive issues.
Novel PDE10A Inhibitor for Acute Schizophrenia Exacerbation Presented at APA Annual Meeting
Borderline Personality Disorder and Online Behaviors: New Information Presented at APA Annual Meeting
Psychiatric Times Board Members Presenting at the 2025 APA Annual Meeting
Curious Chronological Convergences: An Anniversary, Osheroff’s Victory, and Pfister’s Award